<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>7962416</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">33707406</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">7962416</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.12659/MSM.929092</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="publisher-id">929092</article-id></all-ids><extracted-table><table-id>t1-medscimonit-27-e929092</table-id><table-label>Table 1</table-label><table-caption>Baseline characteristics of patients and controls.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="t1-medscimonit-27-e929092" position="float"><label>Table 1</label><caption><p>Baseline characteristics of patients and controls.</p></caption><table frame="hsides" rules="rows"><thead><tr><th valign="middle" align="center" rowspan="1" colspan="1">Characteristics</th><th valign="middle" align="center" rowspan="1" colspan="1">Patients, n=34</th><th valign="middle" align="center" rowspan="1" colspan="1">Controls, n=34</th><th valign="middle" align="center" rowspan="1" colspan="1">P value</th></tr></thead><tbody><tr><td valign="middle" align="left" rowspan="1" colspan="1">Age (years)</td><td valign="middle" align="center" rowspan="1" colspan="1">63.4 [52.1–73.8]</td><td valign="middle" align="center" rowspan="1" colspan="1">61.2 [49.3–70.5]</td><td valign="middle" align="center" rowspan="1" colspan="1">0.532<xref ref-type="table-fn" rid="tfn2-medscimonit-27-e929092">*</xref></td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Female N (%)</td><td valign="middle" align="center" rowspan="1" colspan="1">14 (41.2%)</td><td valign="middle" align="center" rowspan="1" colspan="1">16 (47.1%)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.808<xref ref-type="table-fn" rid="tfn3-medscimonit-27-e929092">**</xref></td></tr><tr><td colspan="4" valign="middle" align="left" rowspan="1">Vascular risk factors N (%)</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Hypertension</td><td valign="middle" align="center" rowspan="1" colspan="1">23 (67.6%)</td><td valign="middle" align="center" rowspan="1" colspan="1">18 (52.9%)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.215<xref ref-type="table-fn" rid="tfn3-medscimonit-27-e929092">**</xref></td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Diabetes</td><td valign="middle" align="center" rowspan="1" colspan="1">19 (55.9%)</td><td valign="middle" align="center" rowspan="1" colspan="1">13 (38.2%)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.145<xref ref-type="table-fn" rid="tfn3-medscimonit-27-e929092">**</xref></td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Hypercholesterolemia</td><td valign="middle" align="center" rowspan="1" colspan="1">20 (58.8%)</td><td valign="middle" align="center" rowspan="1" colspan="1">15 (44.1%)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.225<xref ref-type="table-fn" rid="tfn3-medscimonit-27-e929092">**</xref></td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">NIHSS admission</td><td valign="middle" align="center" rowspan="1" colspan="1">7 [<xref rid="b4-medscimonit-27-e929092" ref-type="bibr">4</xref>–<xref rid="b13-medscimonit-27-e929092" ref-type="bibr">13</xref>]</td><td valign="middle" align="center" rowspan="1" colspan="1">–</td><td valign="middle" align="center" rowspan="1" colspan="1">–</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">MMSE</td><td valign="middle" align="center" rowspan="1" colspan="1">≥21</td><td valign="middle" align="center" rowspan="1" colspan="1">–</td><td valign="middle" align="center" rowspan="1" colspan="1">–</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Lesion size (cm<sup>3</sup>)</td><td valign="middle" align="center" rowspan="1" colspan="1">9.4 [3.2–35.1]</td><td valign="middle" align="center" rowspan="1" colspan="1">–</td><td valign="middle" align="center" rowspan="1" colspan="1">–</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Lesion side (left) N (%)</td><td valign="middle" align="center" rowspan="1" colspan="1">18 (52.9%)</td><td valign="middle" align="center" rowspan="1" colspan="1">–</td><td valign="middle" align="center" rowspan="1" colspan="1">–</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-medscimonit-27-e929092"><p>NIHSS – National Institutes of Health Stroke Scale; MMSE – Mini-Mental State Examination. Continuous variables presented as median [P25–P75].</p></fn><fn id="tfn2-medscimonit-27-e929092"><label>*</label><p>Assessed by Mann-Whitney U test;</p></fn><fn id="tfn3-medscimonit-27-e929092"><label>**</label><p>assessed by chi-square test.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Baseline characteristics of patients and controls.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="rows"><thead><tr><th valign="middle" align="center">Characteristics</th><th valign="middle" align="center">Patients, n=34</th><th valign="middle" align="center">Controls, n=34</th><th valign="middle" align="center">P value</th></tr></thead><tbody><tr><td valign="middle" align="left">Age (years)</td><td valign="middle" align="center">63.4 [52.1–73.8]</td><td valign="middle" align="center">61.2 [49.3–70.5]</td><td valign="middle" align="center">0.532???</td></tr><tr><td valign="middle" align="left">Female N (%)</td><td valign="middle" align="center">14 (41.2%)</td><td valign="middle" align="center">16 (47.1%)</td><td valign="middle" align="center">0.808???</td></tr><tr><td colspan="4" valign="middle" align="left">Vascular risk factors N (%)</td></tr><tr><td valign="middle" align="left">Hypertension</td><td valign="middle" align="center">23 (67.6%)</td><td valign="middle" align="center">18 (52.9%)</td><td valign="middle" align="center">0.215???</td></tr><tr><td valign="middle" align="left">Diabetes</td><td valign="middle" align="center">19 (55.9%)</td><td valign="middle" align="center">13 (38.2%)</td><td valign="middle" align="center">0.145???</td></tr><tr><td valign="middle" align="left">Hypercholesterolemia</td><td valign="middle" align="center">20 (58.8%)</td><td valign="middle" align="center">15 (44.1%)</td><td valign="middle" align="center">0.225???</td></tr><tr><td valign="middle" align="left">NIHSS admission</td><td valign="middle" align="center">7 [???–???]</td><td valign="middle" align="center">–</td><td valign="middle" align="center">–</td></tr><tr><td valign="middle" align="left">MMSE</td><td valign="middle" align="center">≥21</td><td valign="middle" align="center">–</td><td valign="middle" align="center">–</td></tr><tr><td valign="middle" align="left">Lesion size (cm3)</td><td valign="middle" align="center">9.4 [3.2–35.1]</td><td valign="middle" align="center">–</td><td valign="middle" align="center">–</td></tr><tr><td valign="middle" align="left">Lesion side (left) N (%)</td><td valign="middle" align="center">18 (52.9%)</td><td valign="middle" align="center">–</td><td valign="middle" align="center">–</td></tr></tbody></table></div>NIHSS – National Institutes of Health Stroke Scale; MMSE – Mini-Mental State Examination. Continuous variables presented as median [P25–P75].*Assessed by Mann-Whitney U test;**assessed by chi-square test.</transformed-table></extracted-table><extracted-table><table-id>t2-medscimonit-27-e929092</table-id><table-label>Table 2</table-label><table-caption>Clinical and imaging indicators of subjects at different time points.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="t2-medscimonit-27-e929092" position="float"><label>Table 2</label><caption><p>Clinical and imaging indicators of subjects at different time points.</p></caption><table frame="hsides" rules="rows"><thead><tr><th valign="middle" align="center" rowspan="1" colspan="1"/><th valign="middle" align="center" rowspan="1" colspan="1">Controls (n=34)</th><th valign="middle" align="center" rowspan="1" colspan="1">Patients W1 (n=34)</th><th valign="middle" align="center" rowspan="1" colspan="1">Patients W4 (n=34)</th><th valign="middle" align="center" rowspan="1" colspan="1">Patients W12 (n=34)</th></tr></thead><tbody><tr><td valign="middle" align="left" rowspan="1" colspan="1">FMA (0–100)</td><td valign="middle" align="center" rowspan="1" colspan="1">–</td><td valign="middle" align="center" rowspan="1" colspan="1">51.315±9.209</td><td valign="middle" align="center" rowspan="1" colspan="1">73.355±8.854<xref ref-type="table-fn" rid="tfn6-medscimonit-27-e929092">**</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">89.703±7.870<xref ref-type="table-fn" rid="tfn6-medscimonit-27-e929092">**</xref>,<xref ref-type="table-fn" rid="tfn7-medscimonit-27-e929092">***</xref></td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Barthel index (0–100)</td><td valign="middle" align="center" rowspan="1" colspan="1">–</td><td valign="middle" align="center" rowspan="1" colspan="1">54.732±12.937</td><td valign="middle" align="center" rowspan="1" colspan="1">77.708±8.634<xref ref-type="table-fn" rid="tfn6-medscimonit-27-e929092">**</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">86.368±14.409<xref ref-type="table-fn" rid="tfn6-medscimonit-27-e929092">**</xref>,<xref ref-type="table-fn" rid="tfn7-medscimonit-27-e929092">***</xref></td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Interhemispheric FC</td><td valign="middle" align="center" rowspan="1" colspan="1">1.01±0.043</td><td valign="middle" align="center" rowspan="1" colspan="1">0.587±0.119<xref ref-type="table-fn" rid="tfn5-medscimonit-27-e929092">*</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">0.929±0.077<xref ref-type="table-fn" rid="tfn5-medscimonit-27-e929092">*</xref>,<xref ref-type="table-fn" rid="tfn6-medscimonit-27-e929092">**</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">0.969±0.093<xref ref-type="table-fn" rid="tfn5-medscimonit-27-e929092">*</xref>,<xref ref-type="table-fn" rid="tfn6-medscimonit-27-e929092">**</xref>,<xref ref-type="table-fn" rid="tfn7-medscimonit-27-e929092">***</xref></td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">FA in ipsilesional CST</td><td valign="middle" align="center" rowspan="1" colspan="1">0.547±0.058</td><td valign="middle" align="center" rowspan="1" colspan="1">0.448±0.029<xref ref-type="table-fn" rid="tfn5-medscimonit-27-e929092">*</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">0.492±0.033<xref ref-type="table-fn" rid="tfn5-medscimonit-27-e929092">*</xref>,<xref ref-type="table-fn" rid="tfn6-medscimonit-27-e929092">**</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">0.544±0.045<xref ref-type="table-fn" rid="tfn6-medscimonit-27-e929092">**</xref>,<xref ref-type="table-fn" rid="tfn7-medscimonit-27-e929092">***</xref></td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">FA in contralesional CST</td><td valign="middle" align="center" rowspan="1" colspan="1">0.547±0.058</td><td valign="middle" align="center" rowspan="1" colspan="1">0.538±0.055</td><td valign="middle" align="center" rowspan="1" colspan="1">0.544±0.048</td><td valign="middle" align="center" rowspan="1" colspan="1">0.548±0.040</td></tr></tbody></table><table-wrap-foot><fn id="tfn4-medscimonit-27-e929092"><p>FA – fractional anisotropy; FMA – Fugl-Meyer Assessment; FC – functional connectivity. The FA of healthy controls were derived from averages of bilateral CST measurements.</p></fn><fn id="tfn5-medscimonit-27-e929092"><label>*</label><p>Compared with the control group, <italic>P</italic>&lt;0.05 obtained by two-sample independent <italic>t</italic> tests;</p></fn><fn id="tfn6-medscimonit-27-e929092"><label>**</label><p>compared with week 1, <italic>P</italic>&lt;0.05 obtained by RM-ANOVA;</p></fn><fn id="tfn7-medscimonit-27-e929092"><label>***</label><p>compared with week 4, <italic>P</italic>&lt;0.05 obtained by RM-ANOVA.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Clinical and imaging indicators of subjects at different time points.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="rows"><thead><tr><th valign="middle" align="center"/><th valign="middle" align="center">Controls (n=34)</th><th valign="middle" align="center">Patients W1 (n=34)</th><th valign="middle" align="center">Patients W4 (n=34)</th><th valign="middle" align="center">Patients W12 (n=34)</th></tr></thead><tbody><tr><td valign="middle" align="left">FMA (0–100)</td><td valign="middle" align="center">–</td><td valign="middle" align="center">51.315±9.209</td><td valign="middle" align="center">73.355±8.854???</td><td valign="middle" align="center">89.703±7.870???,???</td></tr><tr><td valign="middle" align="left">Barthel index (0–100)</td><td valign="middle" align="center">–</td><td valign="middle" align="center">54.732±12.937</td><td valign="middle" align="center">77.708±8.634???</td><td valign="middle" align="center">86.368±14.409???,???</td></tr><tr><td valign="middle" align="left">Interhemispheric FC</td><td valign="middle" align="center">1.01±0.043</td><td valign="middle" align="center">0.587±0.119???</td><td valign="middle" align="center">0.929±0.077???,???</td><td valign="middle" align="center">0.969±0.093???,???,???</td></tr><tr><td valign="middle" align="left">FA in ipsilesional CST</td><td valign="middle" align="center">0.547±0.058</td><td valign="middle" align="center">0.448±0.029???</td><td valign="middle" align="center">0.492±0.033???,???</td><td valign="middle" align="center">0.544±0.045???,???</td></tr><tr><td valign="middle" align="left">FA in contralesional CST</td><td valign="middle" align="center">0.547±0.058</td><td valign="middle" align="center">0.538±0.055</td><td valign="middle" align="center">0.544±0.048</td><td valign="middle" align="center">0.548±0.040</td></tr></tbody></table></div>FA – fractional anisotropy; FMA – Fugl-Meyer Assessment; FC – functional connectivity. The FA of healthy controls were derived from averages of bilateral CST measurements.*Compared with the control group, P&lt;0.05 obtained by two-sample independent t tests;**compared with week 1, P&lt;0.05 obtained by RM-ANOVA;***compared with week 4, P&lt;0.05 obtained by RM-ANOVA.</transformed-table></extracted-table><extracted-table><table-id>t3-medscimonit-27-e929092</table-id><table-label>Table 3</table-label><table-caption>Multiple linear regression of factors influencing motor recovery.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="t3-medscimonit-27-e929092" position="float"><label>Table 3</label><caption><p>Multiple linear regression of factors influencing motor recovery.</p></caption><table frame="hsides" rules="rows"><thead><tr><th colspan="2" valign="middle" align="center" rowspan="1">Model 1</th><th colspan="2" valign="middle" align="center" rowspan="1">Model 2</th></tr></thead><tbody><tr><td valign="middle" align="left" rowspan="1" colspan="1">R<sup>2</sup></td><td valign="middle" align="center" rowspan="1" colspan="1">0.701</td><td valign="middle" align="left" rowspan="1" colspan="1">R2</td><td valign="middle" align="center" rowspan="1" colspan="1">0.309</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Total (<italic>P</italic> value)</td><td valign="middle" align="center" rowspan="1" colspan="1">&lt;0.001</td><td valign="middle" align="left" rowspan="1" colspan="1">Total (<italic>P</italic> value)</td><td valign="middle" align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Percentage changes of FA(W1–W4)<break/>Beta (<italic>P</italic> value)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.304 (0.011)</td><td valign="middle" align="left" rowspan="1" colspan="1">Percentage changes of FA(W4–W12)<break/>Beta (<italic>P</italic> value)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.557 (0.001)</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Percentage changes of interhemispheric FC(W1–W4)<break/>Beta (<italic>P</italic> value)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.647 (&lt;0.001)</td><td valign="middle" align="left" rowspan="1" colspan="1">Percentage changes of interhemispheric FC(W4–W12)<break/>Beta (<italic>P</italic> value)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.086 (0.571)</td></tr></tbody></table><table-wrap-foot><fn id="tfn8-medscimonit-27-e929092"><p>Beta – standardized regression coefficients. Model 1 with percentage changes of FMA(W1–W4) as dependent variable. Model 2 with percentage changes of FMA(W4–W12) as dependent variable.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Multiple linear regression of factors influencing motor recovery.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="rows"><thead><tr><th colspan="2" valign="middle" align="center">Model 1</th><th colspan="2" valign="middle" align="center">Model 2</th></tr></thead><tbody><tr><td valign="middle" align="left">R2</td><td valign="middle" align="center">0.701</td><td valign="middle" align="left">R2</td><td valign="middle" align="center">0.309</td></tr><tr><td valign="middle" align="left">Total (P value)</td><td valign="middle" align="center">&lt;0.001</td><td valign="middle" align="left">Total (P value)</td><td valign="middle" align="center">&lt;0.001</td></tr><tr><td valign="middle" align="left">Percentage changes of FA(W1–W4)Beta (P value)</td><td valign="middle" align="center">0.304 (0.011)</td><td valign="middle" align="left">Percentage changes of FA(W4–W12)Beta (P value)</td><td valign="middle" align="center">0.557 (0.001)</td></tr><tr><td valign="middle" align="left">Percentage changes of interhemispheric FC(W1–W4)Beta (P value)</td><td valign="middle" align="center">0.647 (&lt;0.001)</td><td valign="middle" align="left">Percentage changes of interhemispheric FC(W4–W12)Beta (P value)</td><td valign="middle" align="center">0.086 (0.571)</td></tr></tbody></table></div>Beta – standardized regression coefficients. Model 1 with percentage changes of FMA(W1–W4) as dependent variable. Model 2 with percentage changes of FMA(W4–W12) as dependent variable.</transformed-table></extracted-table></extracted-tables-set>